Showing results (1-10 of 154) with videos related to
Sort By:
Pageof 16
Cancers|November 13, 2021
New Markers of Disease Progression in MyelofibrosisRita Campanelli, Margherita Massa, Vittorio Rosti, et al.Haematologica|September 5, 2007
Vascular endothelial growth factor promoted endothelial progenitor cell mobilization into the peripheral blood of a patient with POEMS syndromeVittorio Rosti, Margherita Massa, Rita Campanelli, et al.Experimental Hematology|October 16, 2022
Cells coexpressing both myeloid and endothelial markers are detectable in the spleen and bone marrow of patients with primary myelofibrosisRita Campanelli, Carlotta Abbà, Adriana Carolei, et al.Frontiers in Oncology|October 10, 2022
Elevated plasma EDA fibronectin in primary myelofibrosis is determined by high allele burden of JAK2V617F mutation and strongly predicts splenomegaly progressionAlessandro Malara, Cristian Gruppi, Margherita Massa, et al.Genes|August 27, 2021
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and OutcomesLaura Villani, Adriana Carolei, Vittorio Rosti, et al.Plos One|August 2, 2019
Constitutive STAT5 phosphorylation in CD34+ cells of patients with primary myelofibrosis: Correlation with driver mutation status and disease severityCarlotta Abbà, Rita Campanelli, Paolo Catarsi, et al.Cytokine|August 31, 2010
Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosisRita Campanelli, Vittorio Rosti, Laura Villani, et al.Plos One|April 5, 2013
JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosisGiovanni Barosi, Valentina Poletto, Margherita Massa, et al.Annals of the New York Academy of Sciences|July 4, 2002
Murine models of paroxysmal nocturnal hemoglobinuriaVittorio RostiBritish Journal of Haematology|June 24, 2025
Primary myelofibrosis with increased haemoglobin concentration at presentationGiovanni Barosi, Rita Campanelli, Paolo Catarsi, et al.Pageof 16